We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.30 | -2.11% | 60.20 | 61.00 | 62.00 | 61.50 | 60.60 | 61.50 | 47,682 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 24.48M | -2.7M | -0.0382 | -16.10 | 43.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/5/2017 12:32 | Thanks channel. | bamboo2 | |
28/5/2017 08:25 | bamboo2 You asked a question on 5th May to Contact2 regarding a new company formed : There is a 51 page document you can download on Companies House re :- TISSUE REGENIX HOLDINGS LIMITED Company number 10718340 Follow this company File for this company Company Overviewfor TISSUE REGENIX HOLDINGS LIMITED (10718340) Filing historyfor TISSUE REGENIX HOLDINGS LIMITED (10718340) Peoplefor TISSUE REGENIX HOLDINGS LIMITED (10718340) Registered office addressUnit 1 And 2 Astley Way, Astley Lane Industrial Estate, Swillington, Leeds, England, England, LS26 8XT Company status Active Company type Private limited Company Incorporated on 10 April 2017 | channel pirate | |
19/5/2017 21:31 | sp, PUG, Unless a partnership deal can be struck to see meniscus and ligament xenografts through US clinical trials, surely a placing is already on the cards? See the 'paid for' analysis for more info. What this does demonstrate is the fact that the co are looking to have full control over manufacturing of their product within the US. This is key when taken in the context of some of the historical problems that have been associated with US based human donor tissue. Makes me thankful that, in the UK tissue donation is under the umbrella of the NHS in the form of NHSBT, and that for now at least, profit motive is secondary. | bamboo2 | |
19/5/2017 21:03 | swiss paul - fully agree - US legal charge and arm and a leg - very much more expensive than Uk lawyers (who are bad enough) Also wonder what TR are going to use for funds ? | pugugly | |
19/5/2017 20:33 | hmmm solicitors getting involved. I fear tears - best of luck to all | swiss paul | |
19/5/2017 16:15 | Looks interesting. Could change the US set up to TRX's advantage by taking human tissue processing in-house. [It is currently contracted out] I'd guess the xenograft processing could follow in due course, if required, although the Leeds base is of a size that could handle initial requirements, and physical separation of the two lines is preferable. I have an idea that many of the tissue processors in the US are so called 'not for profit' organisations [no pun intended]. I think this is something to do with ethical side of donor tissue, but not sure. | bamboo2 | |
19/5/2017 16:02 | 19 May 2017 Tissue Regenix Group plc Potential Acquisition Leeds, 19 May 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, notes the recent application for a temporary restraining order ("TRO") filed by one of the members of CellRight Technologies, LLC ("CellRight") with Bexar County District Court against CellRight, a US regenerative medicine business based in San Antonio, Texas, in relation to a potential sale of CellRight to Tissue Regenix. Tissue Regenix confirms that it is in discussions with CellRight regarding a possible acquisition of CellRight by Tissue Regenix. There can be no certainty at this stage that the discussions between the Group and CellRight will lead to an acquisition. A further announcement will be made when appropriate. | bamboo2 | |
19/5/2017 14:55 | Looks a great match. | igbertsponk | |
19/5/2017 13:31 | Be one heck of a fit if they did buy Cellright! But it's touch and go that Cellright will not get more interest elsewhere. TRX would have to raise cash perhaps, I don't know how financially set up they are? But as I say...one heck of a good fit! I did have a thought that if someone did outbid trx, then that someone might have a go at them also? Just ramblings.🤔 | rayrac | |
19/5/2017 11:49 | Well! Who would believe it? Where would they get the cash, and are they less than enthusiastic about what they have got? I'm on their mailing list and initially I thought they had received a bid. But as I'm not holding the shares right now, I'm somewhat relieved! | rayrac | |
05/5/2017 15:12 | Thanks bamboo2, so anytime in the next 26 days then !! | channel pirate | |
05/5/2017 14:55 | Contact2, do you have a link to, or other info on, the new co? channel, the co website calender says May '17 for prelims. Last year was on Monday May 23rd. | bamboo2 | |
05/5/2017 12:19 | Let's hope so !! Ref my 2 post above (1899 & 1900) which still have not received a reply, then I also sent an email to enquires@tissueregen | channel pirate | |
05/5/2017 11:53 | Wonder why? Linked to good news perhaps? | rayrac | |
05/5/2017 11:19 | A new company has been created - T R Holdings Limited | contact2fsnetcouk | |
28/4/2017 14:28 | 4 days later and Investor Relations have not replied to my email, so have emailed the same content off to them again. Maybe the person is on holiday and nobody else picks up their emails - just giving them the benefit of the doubt - next week will tell !!!!! | channel pirate | |
24/4/2017 12:54 | Thought I would send an email to Investor Relations at the company this morning - will post the reply should I get one............. Good morning Caitlin, Being a shareholder with a six figure holding it is sad to see some shareholders exiting due to a falling share price and a lack of updates from the company. This time last year the company had already announced via the market of when it was going to report it’s Accounts & Report for the preceding year. Can you advise me of when we are likely to hear from the company in respect of progress and the last financial years Accounts. Thanking you in anticipation. Kind Regards, | channel pirate | |
24/4/2017 11:38 | Hopefully, management have been involved in mega trade deals | contact2fsnetcouk | |
24/4/2017 09:21 | With the company changing their end of year to 31st December from 31st January, one might have thought the end of year Results might have been announced a month earlier this time around. Last year the company announced on the 20th April 2016 that year end Results would be announced on 23rd May 2016. This year................ | channel pirate | |
19/4/2017 15:45 | Weird, unexplained price falls like this, in my (limited!) experience often precedes a cash call, especially in very "leaky" shares. I sold on 22nd March at 15.10p and may buy back if there's no call within a couple of months. I still believe the story, but the market is crowding up somewhat. | loldemort | |
18/4/2017 07:48 | New US website. [In development, but worth exploring.] edit, New UK website too. | bamboo2 | |
23/3/2017 16:37 | Share Price at beginning of the year was 20.5p, and tonight it has fallen to 15.5p, so a 24.39% drop in 3 months. Let's hope we are not going to test the next fib level 'down' !! | channel pirate | |
22/3/2017 14:41 | I'm puzzled by why the price has dropped back again. Given the forecasts, this will be a very profitable company in time, but perhaps investors are running out of their time in waiting. Yes, it is a long haul, but one that will come through in a positive manner in the next year to two, in my belief. In the meantime, I can just pick up a few more from time to time when weakness, such as now, hits. Averaging down is speculative/tricky/r | andrewbaker | |
16/3/2017 10:54 | Hmmm, looks like I added a few more shares too soon, but hey-ho, I'm sure Mr Woodford has a few more shares than me that has been affected !!!!!!!!!!!!!!!!!! | channel pirate | |
15/3/2017 16:48 | I shall be around bamboo! I moved into HUR rather strong, so if you see that succeed, then you'll know I'm here again in force. | rayrac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions